NYAGIM Event: Dr. Maximilien Levesque

Dr. Maximilen Levesque, CEO of Aqemia, will present: "Digital Platform for drug discovery: AI based de novo drug design fueled by free energy calculations".

We will hold the event online, starting at 6:00pm with Maximilien's presentation and Q&A, followed by some time for networking in Zoom breakout rooms for those who can stay and who would like to catch up with the community.

Short Description
"We are an in silico drug discovery company relying on unique quantum-inspired algorithms that predict affinity combined with AI to rapidly discover more innovative molecules with better chances of success"